Additionally, the increase in CD47 expression correlated with increased disease severity in the case of low–risk myelodysplastic syndrome (MDS) to high-risk MDS and the subsequent transition to acute myeloid leukemia (AML) (3). Here, CD47 is linked to myelodysplastic syndrome.